In the News Dec 21, 2020 CEO/CFO Magazine Interview with Jeffrey A. Meckler, Intec's Vice Chairman and Chief Executive Officer 638.3 KB Jun 27, 2019 Accordion Pill Can Ease Motor Fluctuations in People with Advanced Disease, Phase 2 Data Show 80.2 KB Jun 21, 2019 Accordion Pill May Help Reduce Motor Fluctuations in Parkinson’s Disease, Phase 2 Trial Shows 812.2 KB Jun 10, 2019 CEO/CFO Magazine Interview with Nir Sassi, Intec's Chief Financial Officer 155.3 KB Nov 09, 2018 Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019 204.9 KB Oct 26, 2018 Classic Drugs Dealing with Different Health Issues Oct 15, 2018 Jeffrey A. Meckler, Intec Pharma's Vice Chairman and CEO, interview with CEO CFO Magazine 159.3 KB May 24, 2018 Source Smarter Analyst Analysts’ Top Healthcare Picks: NTEC, DERM
Dec 21, 2020 CEO/CFO Magazine Interview with Jeffrey A. Meckler, Intec's Vice Chairman and Chief Executive Officer 638.3 KB
CEO/CFO Magazine Interview with Jeffrey A. Meckler, Intec's Vice Chairman and Chief Executive Officer 638.3 KB
Jun 27, 2019 Accordion Pill Can Ease Motor Fluctuations in People with Advanced Disease, Phase 2 Data Show 80.2 KB
Accordion Pill Can Ease Motor Fluctuations in People with Advanced Disease, Phase 2 Data Show 80.2 KB
Jun 21, 2019 Accordion Pill May Help Reduce Motor Fluctuations in Parkinson’s Disease, Phase 2 Trial Shows 812.2 KB
Accordion Pill May Help Reduce Motor Fluctuations in Parkinson’s Disease, Phase 2 Trial Shows 812.2 KB
Oct 15, 2018 Jeffrey A. Meckler, Intec Pharma's Vice Chairman and CEO, interview with CEO CFO Magazine 159.3 KB